165 related articles for article (PubMed ID: 25814099)
1. Examining endogenous dopamine in treated schizophrenia using [¹¹C]-(+)-PHNO positron emission tomography: A pilot study.
Caravaggio F; Borlido C; Wilson A; Graff-Guerrero A
Clin Chim Acta; 2015 Sep; 449():60-2. PubMed ID: 25814099
[TBL] [Abstract][Full Text] [Related]
2. A Preliminary Investigation of the Effect of Acute Alcohol on Dopamine Transmission as Assessed by [
Thiruchselvam T; Wilson AA; Boileau I; Le Foll B
Alcohol Clin Exp Res; 2017 Jun; 41(6):1112-1119. PubMed ID: 28421623
[TBL] [Abstract][Full Text] [Related]
3. Lack of age-dependent decrease in dopamine D3 receptor availability: a [(11)C]-(+)-PHNO and [(11)C]-raclopride positron emission tomography study.
Nakajima S; Caravaggio F; Boileau I; Chung JK; Plitman E; Gerretsen P; Wilson AA; Houle S; Mamo DC; Graff-Guerrero A
J Cereb Blood Flow Metab; 2015 Nov; 35(11):1812-8. PubMed ID: 26058690
[TBL] [Abstract][Full Text] [Related]
4. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO.
Graff-Guerrero A; Mamo D; Shammi CM; Mizrahi R; Marcon H; Barsoum P; Rusjan P; Houle S; Wilson AA; Kapur S
Arch Gen Psychiatry; 2009 Jun; 66(6):606-15. PubMed ID: 19487625
[TBL] [Abstract][Full Text] [Related]
5. Dopamine D2 and D3 binding in people at clinical high risk for schizophrenia, antipsychotic-naive patients and healthy controls while performing a cognitive task.
Suridjan I; Rusjan P; Addington J; Wilson AA; Houle S; Mizrahi R
J Psychiatry Neurosci; 2013 Mar; 38(2):98-106. PubMed ID: 23010256
[TBL] [Abstract][Full Text] [Related]
6. Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.
Caravaggio F; Kegeles LS; Wilson AA; Remington G; Borlido C; Mamo DC; Graff-Guerrero A
Synapse; 2016 Nov; 70(11):453-60. PubMed ID: 27341789
[TBL] [Abstract][Full Text] [Related]
7. Estimating endogenous dopamine levels at D2 and D3 receptors in humans using the agonist radiotracer [(11)C]-(+)-PHNO.
Caravaggio F; Nakajima S; Borlido C; Remington G; Gerretsen P; Wilson A; Houle S; Menon M; Mamo D; Graff-Guerrero A
Neuropsychopharmacology; 2014 Nov; 39(12):2769-76. PubMed ID: 24874713
[TBL] [Abstract][Full Text] [Related]
8. Dopamine (D2/3) receptor agonist positron emission tomography radiotracer [11C]-(+)-PHNO is a D3 receptor preferring agonist in vivo.
Narendran R; Slifstein M; Guillin O; Hwang Y; Hwang DR; Scher E; Reeder S; Rabiner E; Laruelle M
Synapse; 2006 Dec; 60(7):485-95. PubMed ID: 16952157
[TBL] [Abstract][Full Text] [Related]
9. Exploring the relationship between social attachment and dopamine D
Caravaggio F; Chung JK; Gerretsen P; Fervaha G; Nakajima S; Plitman E; Iwata Y; Wilson A; Graff-Guerrero A
Soc Neurosci; 2017 Apr; 12(2):163-173. PubMed ID: 26873034
[TBL] [Abstract][Full Text] [Related]
10. PET imaging of dopamine-D2 receptor internalization in schizophrenia.
Weinstein JJ; van de Giessen E; Rosengard RJ; Xu X; Ojeil N; Brucato G; Gil RB; Kegeles LS; Laruelle M; Slifstein M; Abi-Dargham A
Mol Psychiatry; 2018 Jun; 23(6):1506-1511. PubMed ID: 28507321
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of Antipsychotic Dose Reduction in Late-Life Schizophrenia: A Prospective Dopamine D2/3 Receptor Occupancy Study.
Graff-Guerrero A; Rajji TK; Mulsant BH; Nakajima S; Caravaggio F; Suzuki T; Uchida H; Gerretsen P; Mar W; Pollock BG; Mamo DC
JAMA Psychiatry; 2015 Sep; 72(9):927-34. PubMed ID: 26131622
[TBL] [Abstract][Full Text] [Related]
12. Nigral Stress-Induced Dopamine Release in Clinical High Risk and Antipsychotic-Naïve Schizophrenia.
Tseng HH; Watts JJ; Kiang M; Suridjan I; Wilson AA; Houle S; Rusjan PM; Mizrahi R
Schizophr Bull; 2018 Apr; 44(3):542-551. PubMed ID: 29036383
[TBL] [Abstract][Full Text] [Related]
13. Reduced insulin sensitivity is related to less endogenous dopamine at D2/3 receptors in the ventral striatum of healthy nonobese humans.
Caravaggio F; Borlido C; Hahn M; Feng Z; Fervaha G; Gerretsen P; Nakajima S; Plitman E; Chung JK; Iwata Y; Wilson A; Remington G; Graff-Guerrero A
Int J Neuropsychopharmacol; 2015 Feb; 18(7):pyv014. PubMed ID: 25716779
[TBL] [Abstract][Full Text] [Related]
14. Effects of antipsychotics on D3 receptors: a clinical PET study in first episode antipsychotic naive patients with schizophrenia using [11C]-(+)-PHNO.
Mizrahi R; Agid O; Borlido C; Suridjan I; Rusjan P; Houle S; Remington G; Wilson AA; Kapur S
Schizophr Res; 2011 Sep; 131(1-3):63-8. PubMed ID: 21684721
[TBL] [Abstract][Full Text] [Related]
15. The dopamine D2 receptors in high-affinity state and D3 receptors in schizophrenia: a clinical [11C]-(+)-PHNO PET study.
Graff-Guerrero A; Mizrahi R; Agid O; Marcon H; Barsoum P; Rusjan P; Wilson AA; Zipursky R; Kapur S
Neuropsychopharmacology; 2009 Mar; 34(4):1078-86. PubMed ID: 18987627
[TBL] [Abstract][Full Text] [Related]
16. Amphetamine-Induced Striatal Dopamine Release Measured With an Agonist Radiotracer in Schizophrenia.
Frankle WG; Paris J; Himes M; Mason NS; Mathis CA; Narendran R
Biol Psychiatry; 2018 Apr; 83(8):707-714. PubMed ID: 29325847
[TBL] [Abstract][Full Text] [Related]
17. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
[TBL] [Abstract][Full Text] [Related]
18. First human evidence of d-amphetamine induced displacement of a D2/3 agonist radioligand: A [11C]-(+)-PHNO positron emission tomography study.
Willeit M; Ginovart N; Graff A; Rusjan P; Vitcu I; Houle S; Seeman P; Wilson AA; Kapur S
Neuropsychopharmacology; 2008 Jan; 33(2):279-89. PubMed ID: 17406650
[TBL] [Abstract][Full Text] [Related]
19. Expression of dopamine D2 and D3 receptors in the human retina revealed by positron emission tomography and targeted mass spectrometry.
Caravaggio F; Scifo E; Sibille EL; Hernandez-Da Mota SE; Gerretsen P; Remington G; Graff-Guerrero A
Exp Eye Res; 2018 Oct; 175():32-41. PubMed ID: 29883636
[TBL] [Abstract][Full Text] [Related]
20. Blockade of [11C](+)-PHNO binding in human subjects by the dopamine D3 receptor antagonist ABT-925.
Graff-Guerrero A; Redden L; Abi-Saab W; Katz DA; Houle S; Barsoum P; Bhathena A; Palaparthy R; Saltarelli MD; Kapur S
Int J Neuropsychopharmacol; 2010 Apr; 13(3):273-87. PubMed ID: 19751545
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
